STOCK TITAN

Insider plans 100,000-share BBIO (NASDAQ: BBIO) sale under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The Form 144 notice for BBIO discloses a planned sale of 100000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 7427000.00. These shares are part of a class with 192708813 shares outstanding and are expected to be sold on or about 01/08/2026 on the NASDAQ.

The securities to be sold were acquired on 03/26/2016 via conversion of management incentive units from the issuer, with no gift indicated. The notice also lists multiple Rule 10b5-1 sales of common stock during the prior three months for accounts associated with NEIL KUMAR and related trusts, each disclosing the date, number of shares sold, and gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the BBIO Form 144 filing disclose?

The Form 144 notice discloses a planned sale of 100000 BBIO common shares with an aggregate market value of 7427000.00, to be sold on the NASDAQ.

How many BBIO shares are outstanding in this Form 144?

The filing states that the class of common stock has 192708813 shares outstanding.

When were the BBIO shares in this Form 144 originally acquired?

The 100000 common shares to be sold were acquired on 03/26/2016 through a conversion of management incentive units from the issuer.

Which broker is handling the planned BBIO share sale in this Form 144?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker.

What prior Rule 10b5-1 sales are reported in the BBIO Form 144?

The notice lists multiple Rule 10b5-1 sales of BBIO common stock in October, November, and December 2025 for NEIL KUMAR and related revocable and irrevocable trusts, each with specific share amounts and gross proceeds.

What does the Form 144 say about the seller19s knowledge of BBIO information?

The signer represents that the person for whose account the securities are to be sold does not know any material adverse information about BBIO19s current or prospective operations that has not been publicly disclosed.

Bridgebio Pharma

NASDAQ:BBIO

BBIO Rankings

BBIO Latest News

BBIO Latest SEC Filings

BBIO Stock Data

14.70B
166.55M
4.77%
101.53%
10.41%
Biotechnology
Pharmaceutical Preparations
Link
United States
PALO ALTO